title: Angiogenic cytokines in patients with idiopathic interstitial pneumonia.
abstract: BACKGROUND
  Angiogenesis has been implicated in the pathogenesis of idiopathic interstitial pneumonia (IIP). The aim of this study was to examine the relationship between plasma concentrations of the angiogenic cytokines interleukin 8 (IL-8), vascular endothelial growth factor (VEGF), and endothelin-1 (ET-1) and clinical parameters of disease progression over a 6 month period to identify potential aetiological mediators and prognostic markers of disease activity in patients with IIP.
  
  
  METHODS
  Forty nine patients with IIP (40 men) were recruited to the study. Plasma cytokine measurements, pulmonary function tests, and high resolution computed tomography (HRCT) scans were performed on recruitment and after 6 months. Plasma cytokine measurements were also performed in 15 healthy volunteers for control purposes.
  
  
  RESULTS
  Patients with IIP had significantly higher median (IQR) baseline concentrations of IL-8 and ET-1 than controls (155 (77-303) pg/ml v 31 (0-100) pg/ml, p<0.001) and (1.21 (0.91-1.88) pg/ml v 0.84 (0.67-1.13) pg/ml, p<0.01), respectively. Baseline concentrations of IL-8, ET-1, and VEGF were significantly related to the baseline HRCT fibrosis score (r = 0.42, p<0.005; r = 0.39, p<0.01; and r = 0.42, p<0.005, respectively). Patients with IIP who developed progressive disease had significantly higher baseline levels of IL-8 (345 (270-497) pg/ml v 121 (73-266) pg/ml, p = 0.001) and VEGF (1048 (666-2149) pg/ml v 658 (438-837) pg/ml, p = 0.019). Over 6 months the change in VEGF was significantly related to the change in HRCT fibrosis score (r = 0.565, p = 0.035) and negatively related to the change in forced vital capacity (r = -0.353, p = 0.035).
authors.affiliation: North West Lung Research Centre, South Manchester University NHS Hospitals Trust, Wythenshawe Hospital, Manchester M23 9LT, UK.
authors.forename: N R
authors.initials: NR
authors.lastname: Simler
authors.forename: P E
authors.initials: PE
authors.lastname: Brenchley
authors.forename: A W
authors.initials: AW
authors.lastname: Horrocks
authors.forename: S M
authors.initials: SM
authors.lastname: Greaves
authors.forename: P S
authors.initials: PS
authors.lastname: Hasleton
authors.forename: J J
authors.initials: JJ
authors.lastname: Egan
mesh_terms: D000328:Adult; D016207:Cytokines / Q000097:blood; D019332:Endothelin-1 / Q000097:blood*; D005260:Female; D005541:Forced Expiratory Volume / Q000502:physiology; D006801:Humans; D016209:Interleukin-8 / Q000097:blood*; D008168:Lung / Q000098:blood supply*; D017563:Lung Diseases, Interstitial / Q000097:blood* / Q000473:pathology / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D009389:Neovascularization, Pathologic / Q000097:blood; D011446:Prospective Studies; D012372:ROC Curve; D014109:Total Lung Capacity / Q000502:physiology; D042461:Vascular Endothelial Growth Factor A / Q000097:blood*; D014797:Vital Capacity / Q000502:physiology
chemical_list: D016207:Cytokines; D019332:Endothelin-1; D016209:Interleukin-8; D042461:Vascular Endothelial Growth Factor A